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white matter glial responses in a mouse
model of chronic cerebral hypoperfusion
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Abstract
Background: This study was designed to explore the beneficial effects of environmental enrichment (EE) on white
matter glial changes in a mouse model of chronic cerebral hypoperfusion induced by bilateral common carotid
artery stenosis (BCAS).
Methods: A total of 74 wild-type male C57BL/6J mice underwent BCAS or sham surgery. One week after surgery,
the mice were randomly assigned into three different groups having varied amounts of EE—standard housing with
no EE conditions (std), limited exposure with 3 h EE a day (3 h) and full-time exposure to EE (full) for 12 weeks. At
16 weeks after BCAS surgery, behavioural and cognitive function were assessed prior to euthanasia. Brain tissues
were analysed for the degree of gliosis including morphological changes in astrocytes and microglia.
Results: Chronic cerebral hypoperfusion (or BCAS) increased clasmatodendrocytes (damaged astrocytes) with
disruption of aquaporin-4 immunoreactivity and an increased degree of microglial activation/proliferation. BCAS
also impaired behavioural and cognitive function. These changes were significantly attenuated, by limited exposure
compared to full-time exposure to EE.
Conclusions: Our results suggest that moderate or limited exposure to EE substantially reduced glial damage/activation.
Our findings also suggest moderate rather than continuous exposure to EE is beneficial for patients with subcortical
ischaemic vascular dementia characterised by white matter disease-related inflammation.
Keywords: Animal model, Chronic cerebral hypoperfusion, Clasmatodendrosis, Environmental enrichment, Glial
activation/proliferation
Background
Dementia resulting from cerebrovascular disorders is the
second most prevalent type of dementia [1] which cur-
rently has no cure. Therefore, effective and safe thera-
peutic strategies, which delay or slow the progression of
vascular dementia (VaD) symptoms, are urgently required.
Subcortical ischaemic vascular dementia (SIVD), the most
common subtype of VaD, has a strong relationship to
vascular cognitive impairment (VCI) [2]. SIVD is char-
acterised by lacunar infarcts and white matter (WM)
lesions [3, 4] and plays a key role for VCI [5]. Cerebral
hypoperfusion is defined as decreased cerebral blood
flow (CBF) evident in VaD, which may promote WM
lesions [2], frontal hypo-metabolism [6] and cognitive
impairment [7]. Chronic cerebral hypoperfusion, a major
component of SIVD and diffuse WM changes caused by
small-vessel disease (SVD), is also strongly correlated
with VCI in SIVD patients [8, 9]. However, little is
known about the neuropathological mechanisms that
lead SIVD patients to progress to VCI.
Animal models of chronic cerebral hypoperfusion have
been studied in rats [10–13] and gerbils [14] in order to
understand the neuropathological processes that occur
in the progression of SVD. Our research group has
established several relevant models of VCI/VaD by
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assessing chronic cerebral hypoperfusion models in ro-
dents [15–20]. Notably, a mouse model of chronic cere-
bral hypoperfusion induced by common carotid artery
stenosis (BCAS) has been evaluated as one of the most
reliable rodent models of VaD [21–23]. These models
exhibited glial changes, i.e. astrogliosis and microglial
proliferation in WM.
Astrocytes are a major factor in the maintenance of
brain homeostasis and can be neuroprotective by redu-
cing reactive oxygen species following brain ischaemia
[24]. However, once astrocyte morphology is changed
in aged humans and rodents [25], proliferated astro-
cytes, which is indicative of reactive astrogliosis [26],
may have detrimental effects in response to various
brain injuries, i.e. stroke [27] and enhance neuronal
damage [28].
Chronic neurodegenerative diseases are accelerated by
inflammatory response, and both microglia and astro-
cytes are accountable for this inflammatory response in
the brain, i.e. glial proliferation and activation [29]. Fol-
lowing neuronal or glial damage, inflammatory response,
characterised by microglial activation/proliferation, has
been demonstrated as having both beneficial and detri-
mental effects in various neurological diseases, e.g.
stroke and Alzheimer’s disease [30]. However, chronic
over-activation of microglia may cause progressive
neurotoxic effects in the brain [31].
The environmental enrichment (EE) paradigm has been
established to determine environment-induced plasti-
city through, e.g. social interaction and physical activity
[32]. EE has been demonstrated to improve cognitive
impairment in humans, and possibly reverse WM dam-
age. There is some evidence that EE could enhance syn-
aptic plasticity and attenuate cognitive deficits in
rodents [33–36] and man [37]. These studies reported
that EE increased brain plasticity, enhanced neurogen-
esis, and increased synaptogenesis as well as preserving
motor and cognitive function. EE has also been re-
ported to enhance recovery after stroke injury by at-
tenuating microglia-related inflammatory responses via
the Toll-like receptor 2 (TLR2) [38]. However, although
several previous studies reported the beneficial effects
of EE in rodents and man, few studies explored the pro-
tective effects of graded degrees of EE against glial
damage in WM and possibly VaD.
This study investigated the effects of EE on glial damage
and pathological sequelae in a mouse model of chronic
cerebral hypoperfusion induced by bilateral common ca-
rotid artery stenosis (BCAS), with the aim of identifying
effective and safe novel interventional strategies for VCI/
VaD. We focused on the question of whether glial re-
sponses in the WM induced by BCAS can be modified by
readily implemented EE intervention and therefore SIVD-
related cellular inflammatory responses.
Methods
Animals and surgical procedures
Figure 1a shows the experimental paradigm of the
study. Male C57BL/6J mice (9 weeks old, 23.1−25.3 g)
were purchased from the Jackson Laboratory, USA.
The mice were housed within a 12-h day and 12-h
night cycle (6 am–6 pm, day; 6 pm–6 am, night) and
were given access to food and water ad libitum. After
1-week acclimatisation, a total of 74 mice were ran-
domly chosen for either bilateral common carotid ar-
tery stenosis (BCAS, n = 41) or sham (n = 33) surgery.
BCAS surgery was performed as described previously
[15]. Briefly, mice were anaesthetised by 1.5% isoflurane
in oxygen and air. A middle neck incision was made;
bilateral common carotid arteries (CCAs) were exposed
and isolated from the vagus nerves. Microcoils, inner
diameter of 0.18 mm (Sawane Spring, Japan), were ap-
plied to both CCAs. Sham animals were exposed to the
same operative procedures as BCAS mice, except for
the application of microcoils. Body temperature was
monitored and maintained between 36.5 and 37.5 °C
with the aid of a feedback warming pad and a blanket
during the operative procedure. Animals were appro-
priately identified with coded numbers. All of the
experiments and data analyses were performed under
investigator-blinded conditions. Animals dying during
the experimental period and before the planned eutha-
nisation at 16 weeks after surgery were excluded from
further analyses. All procedures were pre-approved by
the Home Office, London, UK based upon ASPA: The
Animals (Scientific Procedures) Act 1986, UK and per-
formed in accordance with the guidelines stipulated by
the ethical committee of Newcastle University and ad-
hering to ARRIVE guidelines.
Environmental enrichment (EE) paradigm and animal
groups
Animal were divided into two main groups, sham and
BCAS (Fig. 1b). One week after surgery, mice were
randomly assigned to six subgroups: Sham-std, sham-
operated mice with standard housing; Sham-3 h, sham-
operated mice with limited exposure to EE: Sham-full,
sham-operated mice with full-time exposure to EE;
BCAS-std, BCAS operated mice with standard housing;
BCAS-3 h, BCAS operated mice with limited exposure
to EE and BCAS-full, BCAS operated mice with full-
time exposure to EE. Standard housing (Fig. 1c(A)) de-
notes a normal housing condition, which incorporated
a paper house and shredded tissue. EE cages (Fig. 1c(B))
had extra toys in addition to the standard housing, e.g.
running wheels, hanging chains, igloos and a paper
tunnel. Limited exposure to EE was performed as de-
scribed previously [39]. Briefly, for the first 4 weeks,
mice were transferred to the EE cages for 3 h every day
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in the morning from 9 am to 12 pm. From 5th week to
12th week, mice experienced EE cages for 3 h, 3 days a
week. Full-time exposure to EE group experienced an
EE environment every day for 24 h over the entire
12 weeks. In this study, the experimental animals (sur-
vivors) were divided into six groups as follows: Sham-
std, sham-operated mice with standard housing, n = 11;
Sham-3 h, sham-operated mice with intermittent ex-
posure to EE, n = 11; Sham-full, sham-operated mice
with full-time exposure to EE, n = 11; BCAS-std, BCAS
operated mice with standard housing, n = 13; BCAS-
3 h, BCAS operated mice with intermittent exposure to
EE, n = 10; BCAS-full, BCAS operated mice with full-
time exposure to EE, n = 12.
Nesting behaviour
The Nestlets™ (Ancare, USA) test was used to assess
the nesting ability of mice [40] before BCAS or sham
surgery (as baseline) as well as 16 weeks after surgery
before euthanasia. Briefly, one Nestlet, composed of a
pressed square of cotton material (2 × 2 in.) was placed
at one corner of each cage at 4 pm and left there over-
night. First, mice shredded the tightly packed cotton
material and then arranged it into a nest. Next morning
at 10 am, each cage was assessed in terms of the ap-
pearance of the nest (Nestlet score), height of the nest
(cm) and the percentage Nestlet used (%). Scoring was
defined as follows [40]: 1, Nestlet not noticeably touched
(more than 90% intact); 2, Nestlet partially torn (50–90%
Fig. 1 Experimental protocol and animal groups. a Experimental protocol − BCAS, bilateral common carotid artery stenosis; EE, environmental
enrichment. b Animal groups and the number of animals in each group. Sham-std, n = 11; Sham-3 h, n = 11; Sham-full, n = 11; BCAS-std, n = 13,
BCAS-3 h, n = 10; BCAS-full, n = 12. c(A and B) Images of standard housing cage (A) and EE cage (B)
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remaining intact); 3, Nestlet mostly shredded but often
no identifiable nest site: less than 50% of the Nestlet re-
mains intact, but less than 90% is within a quarter of the
cage floor area, i.e. the cotton is not gathered into a nest
but is spread around the cage. The material may some-
times be in a broadly defined nest area, but the critical
definition is that 50–90% is shredded; 4, An identifiable
but flat nest: >90% of the Nestlet is torn and the material
is gathered into a nest within a quarter of the cage floor
area, but the nest is flat, with walls higher than the aver-
age mouse BW for less than 50% of its circumference; 5,
A (near) perfect nest: more than 90% of the Nestlet is
torn and the nest is a crater, with walls higher than the
average mouse BW for >50% of its circumference.
Cognitive function assessed by an innovative three-
dimensional nine-arm radial maze
Cognitive function (mainly working memory) was assessed
in each mouse from 13 weeks post BCAS surgery during
a period of 20 days, using an innovative three-
dimensional (3D) nine-arm radial maze (3D-RAM) [41].
This was a modified version of the conventional eight-
arm radial maze. Behavioural tests were performed in a
dimly lit behavioural testing room. The 3D maze (grey
PVC, 5 mm thick) consisted of nine arms connected to
bridges (slope part) radiating from a central platform.
Each arm (35 cm × 11.2 cm) was attached to a bridge
(slope part at 40°, 15.2 cm × 11.2 cm). The surface of the
bridge was made of metal mesh, which enabled mice to
maintain grip. A small transparent wall panel (9 cm ×
6 cm) was randomly placed at each entrance of a bridge
in order to narrow entry, which avoids a continuous
sequential entry from one bridge to the next. In order to
enter each arm, mice paced in the centre platform and
needed to cross a bridge (elevated ramp) [41]. At the
end of each arm, a small pellet (Dustless Precision Pellets®
Rodent, Purified, Bio Serv, USA) was placed in order to
entice food-restricted mice to enter the arm. Different
colours/shapes of pictures were placed vertically at the
end of each arm as visual cues, enabling mice to distin-
guish individual arms. The maze was placed at the
centre of a behavioural test room affixed during the
entire testing period. All of the sessions for each mouse
were streamed and recorded using a camcorder (LEGRIA
HF R56, Canon), suspended directly over the maze, via a
Wi-Fi network to an iPad (Apple Inc., USA), which was
sited outside the behavioural test room.
A day before the first session, each mouse was
weighed to ascertain body weight and food deprivation
was induced to achieve 10% reduction in their body
weight. Mice were weighed immediately prior to each
testing session to ensure their BW was maintained at
90% of baseline level. Mice were randomly tested for 20
consecutive days without prior habituation to the maze
[42, 43]. Mice placed into a transparent plastic beaker
(7 cm diameter, 18.5 cm height) were gently introduced
on the central platform at the start of each session. The
session was terminated when each mouse completed
nine-arm entries or when 10 min had elapsed. After
each session, the mouse was allowed to return to the
central platform before removing it from the maze in a
similarly gentle manner. Between each session, the maze
was cleaned with hypochlorous acid-soaked tissue
followed by distilled water to remove any trace smells
left by urine or faeces. The number of arm entries before
first repeat was recorded in each session. The number of
arm entries before first repeat in every consecutive 10
sessions and overall 20 sessions were averaged.
Histopathological analysis
Mice were anaesthetised by intraperitoneal injection of
sodium pentobarbital (50 mg/kg). Mice were perfused
transcardially at 20 ml/min with 0.01 M phosphate-buff-
ered saline (PBS), pH 7.4. The right or left hemisphere of
each brain was randomly selected for histological analysis
and subsequently post-fixed in 4% paraformaldehyde
(PFA) in 0.01 M PBS (pH 7.4) for 48 h. Brains were cut
into five blocks at different coronal levels after fixation:
block OB, coronal level of olfactory bulb; block 1, coronal
level of bregma +0.5 mm; block 2, coronal level of bregma
−1.0 mm; block 3, coronal level of bregma −2.0 mm; block
4, level of cerebellum and brain stem. Each fixed sub-
dissected brain block was dehydrated and embedded in
paraffin. Five-micrometer-thick sections were cut using
a rotary microtome and then mounted on glass slides,
stained and analysed.
Immunohistochemistry/immunofluorescence
Immunohistochemistry
Five-micrometer-thick sections obtained from block 3;
coronal level of bregma +2.0 mm were used for immu-
nohistochemical analysis of each brain. Immunohisto-
chemistry for glial fibrillary acid protein (GFAP), a
marker of astrocytes and ionised calcium-binding
adapter molecule-1 (Iba-1), a marker of microglial were
performed. Increased GFAP immunoreactivity was used
as a marker for astrocytic activation. Antigen retrieval
was performed by using 12 min heating in a microwave
oven with citrate buffer, pH 6.0 before the sections
were then quenched with 3% hydrogen peroxide in
phosphate-buffered saline (PBS). Tissues were blocked
with normal goat serum, which was derived from the
species in which the secondary antibody was generated,
for 30 min. After the blocking process, sections were
treated with primary antibodies against GFAP (1:2000,
DAKO) and Iba-1 (1:200, Wako, Osaka, Japan), 4 °C
overnight followed by incubation with an appropriate
secondary antibody (biotinylated anti-IgG; 1:200, Vector
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Laboratories, USA) for 1 h at room temperature. Visual-
isation for standard colour immunohistochemistry was
performed using the Vectastain ABC System (Vector
Laboratories) for 30 min at room temperature.
GFAP-positive astrocytes and clasmatodendorocytes
Images of GFAP-stained cells within the entire corpus cal-
losum (CC) were captured using a bright field microscope
(Leitz DIALUX 20, Leica) with a ×20 objective lens
coupled to a lumenera infinity digital camera (Lumenera
Corporation, Canada). All GFAP-positive astrocytes and
clasmatodendrocytes (damaged astrocytes), characterised
by enlarged cell bodies with short processes [44], from
each image were counted to assess the total number of as-
trocytes and clasmatodendrocytes. Using ImageJ software,
each CC area was traced and measured (pixels and mm2)
to calculate percentage of the GFAP-stained area per en-
tire CC area (pixels/pixels, %) as well as numerical density
of GFAP-positive astrocytes and clasmatodendrocytes
(/mm2). Percentage of GFAP-positive clasmatodendro-
cytes per total number of GFAP-positive astrocytes (%)
was also calculated. Furthermore, the numerical density
of GFAP-positive clasmatodendrocytes or percentage of
GFAP-positive clasmatodendrocytes per total GFAP-
positive astrocytes, and CC volume were correlated.
Iba-1-positive microglia and microglial activation
Images of Iba-1-stained cells were captured as described
previously, using a bright field microscope and a digital
camera. All Iba-1-positive microglia from each image
were counted to assess the total number of microglia in
the entire CC. In addition, all of the Iba-1-positive
microglia with the minimal diameter of their cell bodies
exceeding 7 or 10 μm (activated microglia) and less
than 7 μm (non-activated microglia) were counted to
assess the degree of microglial activation. Detailed ana-
lysis of microglial morphology, i.e. enlarged cell bodies
with thicker and less radially projecting processes was
considered to define microglial activation. Using ImageJ
software, each CC area was traced and measured (pixels
and mm2) to calculate percentage of Iba-1-stained area
per CC area (pixels/pixels, %) as well as numerical
density of Iba-1-positive microglia, Iba-1-positive activated
and non-activated microglia (/mm2) in the entire CC.
Immunofluorescence
Sections obtained from block 3, coronal level of bregma
+2.0 mm, were used for immunofluorescent analysis of
each brain. Double immunofluorescent staining for
GFAP and aquaporin-4 (AQP4) was performed. Five-
micrometer-thick brain sections were dewaxed and rehy-
drated. Antigen retrieval and blocking were performed
using the exact same procedure previously described for
immunohistochemical staining. After the blocking process,
sections were treated with primary antibodies against
GFAP (1:2000, DAKO) and AQP4 (1:50, Proteintech), 4 °C
overnight followed by incubation with an appropriate sec-
ondary antibody (Dylight 650 conjugated anti-IgG, 1:100,
Thermo Scientific, for GFAP; Texas Red conjugated anti-
IgG, 1:200, Life Technologies, for AQP4) for 1 h at room
temperature. Images were captured from the CC using
confocal microscopy (TCS SP8, Leica microsystems). Ten
consecutive levels were imaged (Z-stacks) through the sec-
tion, and a merged 2D image was generated. Distribution
of AQP4 immunoreactivity in each cell was analysed,
and percentage of AQP4 dislocation was calculated in
the entire CC.
Statistical analysis
Data are expressed as mean ± SEM. Using IBM SPSS sta-
tistics 22 software, non-paired t-test or one-way analysis
of variance (ANOVA) followed by post-hoc Tukey’s test
were performed for multiple comparison of each group.
Pearson’s correlation analysis was performed for asses-
sing correlation between clasmatodendrosis and CC
volume. P < 0.05 was defined as statistically significant
in all analyses.
Results
Survival rate of animals in this study
All sham-operated mice (n = 33) survived until 16 weeks
after surgery. However, survival rate of the BCAS mice
was 85.4% (35 of original 41 mice) at 16 weeks after sur-
gery. The survival rates of the BCAS subgroups were as
follows: BCAS-std 92.9% (13 of 14), BCAS-3 h 91.0%
(10 of 11); BCAS-full 75% (12 of 16). The six causes of
deaths in the BCAS group were cerebral haemorrhage
(n = 1), severe enterocolitis (n = 1), kidney anomaly (n = 1)
and acute renal failure due to dehydration (n = 3). The
final number of survivors in each group was Sham-std,
n = 11; Sham-3 h, n = 11; Sham-full, n = 11; BCAS-std,
n = 13, BCAS-3 h, n = 10; BCAS-full, n = 12.
Effects of EE on astrogliosis and clasmatodendrosis in CC
BCAS induced astrogliosis, characterised by increased
percentage of GFAP-stained area as well as increased
numerical density of GFAP-positive astrocytes in the
entire CC (Fig. 2a–c). This was evident as both hyper-
trophic and hyperplastic responses. Limited exposure to
EE (BCAS-3 h) reduced % GFAP-stained area compared
with BCAS-std (P < 0.01) (Fig. 2b) and the numerical
density of GFAP-positive astrocytes in the entire CC
compared with BCAS-std and BCAS-full subgroups
(both P < 0.01) (Fig. 2c). BCAS-full also showed reduced
% GFAP-stained area and numerical density of GFAP-
positive astrocytes in the entire CC compared with
BCAS-std (both P < 0.01) (Fig. 2b, c). There were no dif-
ferences between BCAS-3 h and all sham subgroups in %
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Fig. 2 (See legend on next page.)
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GFAP immunoreactivity per whole CC area (Fig. 2b, c).
BCAS-full subgroup showed no difference between all
Sham subgroups in % GFAP-stained area per whole CC
area (Fig. 2b). BCAS also induced clasmatodendrosis:
significantly increased damaged astrocytes in the CC
(Fig. 2d, e). Limited exposure to EE (BCAS-3 h) subgroup
exhibited reduced density of GFAP-positive clasmatoden-
drocytes in the entire CC and % of clasmatodendrocytes
per all GFAP-positive astrocytes compared with BCAS-std
(P < 0.01) (Fig. 2d, e). BCAS-3 h subgroup also showed
reduced density of GFAP-positive clasmatodendrocytes
compared with BCAS-full (P < 0.05) (Fig. 2d) and % of
clasmatodendrocytes per all GFAP-positive astrocytes
compared with BCAS-std (P < 0.01) (Fig. 2e). BCAS-full
showed reduced density of GFAP-positive clasmatoden-
drocytes as well as reduced % of clasmatodendrocytes per
all GFAP-positive astrocytes compared with BCAS-std
(Fig. 2d, e). There were no differences between BCAS-3 h
and all sham subgroups in the density of GFAP-positive
clasmatodendrocytes (Fig. 2d).
Degree of clasmatodendrosis correlated with CC atrophy
Increased clasmatodendrosis in the atrophied CC was
most evident in BCAS-std followed by BCAS-full across
BCAS subgroups. Limited exposure to EE (BCAS-3 h)
tended to show less clasmatodendrosis in the relatively
preserved larger CC (Fig. 2f, g). The density of clasmato-
dendrocytes was negatively correlated with CC volume
(r = 0.615, P < 0.01) (Fig. 2f ). Percentage of clasmatoden-
drocytes per all GFAP-positive astrocytes was also nega-
tively correlated with CC volume in the BCAS cohort
(r = 0.583, P < 0.01) (Fig. 2g).
Abnormal distribution of aquaporin-4 (AQP4) within
GFAP-positive astrocytes
In sham subgroups, aquaporin-4 (AQP4) was normally
distributed within GFAP-positive astrocytic end-feet around
the vessels (Fig. 3a(A–C)). Abnormal distribution of AQP4,
characterised by loss or retraction of the astrocytic end-feet
around the vessels and abnormal aggregation of AQP4
at the periphery of GFAP-positive astrocytes/clasmato-
dendrocytes, was most evident in the BCAS-std animals
followed by BCAS-full (Fig. 3a(D, F). Limited exposure
to EE (BCAS-3 h) effectively reduced the abnormal dis-
tribution of AQP4 in the CC (Fig. 3a(E), b).
Microglial proliferation and activation induced by BCAS
Microglial proliferation and activation in the CC were
evident in BCAS-std subgroup (Fig. 4a–f ). Limited
exposure to EE (BCAS-3 h) suppressed microglial pro-
liferation, characterised by an increased % Iba-1-stained
area per entire CC area and increased density of Iba-1-
positive microglia per entire CC area (both P < 0.01)
(Fig. 4b, c). BCAS-3 h also suppressed degree of
microglial activation in both moderately (microglial
cell body >7 μm) (P < 0.01) (Fig. 4d) and highly (micro-
glial cell body >10 μm) activated (P < 0.05) (Fig. 4e)
levels, as well as suppressing the number of non-
activated microglial cells (P < 0.01) (Fig. 4f ). BCAS-full
also attenuated microglial proliferation and activation
(Fig. 4b–f ); however, this was more effective in the
BCAS-3 h animals than the BCAS-full animals. BCAS-
full did not suppress highly activated microglia in the
CC compared with BCAS-std (Fig. 4e). There were no
differences evident between BCAS-3 h or BCAS-full
and all sham subgroups.
Impaired nesting ability induced by BCAS was reversed
by EE
Sham subgroups had almost the same level of nesting
ability (Nestlet score) compared with preoperative base-
line level at 16 weeks after surgery (Fig. 5a(A–D)). How-
ever, BCAS-std subgroup exhibited lower Nestlet scores
(impaired nesting ability) compared to baseline level (*P <
0.05) (Fig. 5a(A, B)). EE reversed impaired nesting ability,
and limited exposure to EE (BCAS-3 h) tended to improve
(See figure on previous page.)
Fig. 2 Assessment of astrogliosis and clasmatodendrosis in the corpus callosum (CC). a(A–F) Representative images of GFAP-stained corpus callosum
(CC) in each group. a(A) Sham-std; a(B) Sham-3 h; a(C) Sham-full; a(D) BCAS-std; a(E) BCAS-3 h; a(F) BCAS-full. Scale bar represents 25 μm. a(A–C) Arrow
heads indicate normal astrocytes. a(D–F) Arrows indicate clasmatodendrocytes. b–c, Histograms showing GFAP-positively stained astrocytes per area of
CC (% GFAP-stained area) (b) as well as numerical density of GFAP-positive astrocytes in the entire CC (c). BCAS-3 h showed decreased GFAP-stained
area and decreased numerical density of GFAP-positive astrocytes in the entire CC compared with BCAS-std (**P < 0.01). BCAS-full showed decreased
GFAP-stained area in the entire CC compared with BCAS-std (**P < 0.01) (b, c). BCAS-3 h also showed decreased numerical density of GFAP-positive
astrocytes in the entire CC compared with BCAS-full (**P < 0.01) (c). d, e Histograms showing numerical density of GFAP-positive clasmatodendrocytes
(damaged astrocytes) in the entire CC (d) and percentage of clasmatodendrocytes per total number of GFAP-positive astrocytes in the entire CC (e).
BCAS-3 h and BCAS-full showed reduced numerical density of GFAP-positive clasmatodendrocytes in the entire CC and % of clasmatodendrocytes
per all GFAP-positive astrocytes compared with BCAS-std (**P < 0.01) (d and e). BCAS-3 h also showed reduced numerical density of GFAP-positive
clasmatodendrocytes in the entire CC compared with BCAS-full (*P < 0.05) (d) and % of clasmatodendrocytes per all GFAP-positive astrocytes
compared with BCAS-std (**P < 0.01) (e). f, g Histograms showing negative correlation between numerical density of clasmatodendrocytes and
CC volume (f) as well as correlation between % of clasmatodendrocytes and CC volume (g) in the CC of BCAS cohort. Pearson’s correlation
analysis revealed that degree of clasmatodendrosis in the CC of BCAS cohort exhibited strong negative correlation with CC atrophy (r = 0.615,
P < 0.01, between numerical density of clasmatodendrocytes and CC volume, (f); r = 0.583, P < 0.01, between % of clasmatodendrocytes in the
CC and CC volume, (g)). Sham-std, n = 11; Sham-3 h, n = 11; Sham-full, n = 11; BCAS-std, n = 13, BCAS-3 h, n = 10; BCAS-full, n = 12
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nesting ability compared with BCAS-std and BCAS-full
subgroups (Fig. 5b). BCAS plus EE subgroups made
higher nests, used more Nestlet to make nests compared
with BCAS-std (Fig. 5a(C, D)).
Impaired working memory induced by BCAS was partially
reversed by EE
Working memory was significantly impaired in BCAS
compared to sham animals. The number of arm entries
before first repeat was lower in BCAS mice compared to
the sham in sessions 1–10, 11–20 and 1–20 (all P < 0.01)
(Fig. 5b(A)). All sham subgroups also completed more
arm entries before first repeat compared with all BCAS
subgroups. Between BCAS subgroups, the BCAS-3 h
mice subgroup completed more arm entries before first
repeat, in sessions 1–10, 11–20 and 1–20 (Fig. 5b(B)).
Discussion
We report on the favourable effects of EE on WM glial
damage in the BCAS mouse model. We found that
chronic cerebral hypoperfusion induced by bilateral
common carotid artery stenosis (BCAS) caused (1)
astrogliosis, clasmatodendrosis (increased number of
clasmatodendrocytes); (2) microglial proliferation/acti-
vation in the corpus callosum (CC); and (3) impaired
nesting ability and cognitive function. This study pro-
vides strong evidence to support the notion that limited
EE could suppress brain hypoperfusion-induced glial
damage in WM and neuroinflammation in VCI and
possibly VaD patients.
Our observations are consistent with recent studies
on the pathophysiology of the WM in post-stroke de-
mentia (PSD). We found highly increased degeneration
of astrocytes in PSD subjects who had greater WM
hyperintensity volumes [45]. Clasmatodendrosis, dam-
aged astrocytes with enlarged cell bodies and loss of
processes, was particularly prominent in the deep WM
of the frontal lobe [44]. Similarly, increased degree of
clasmatodendrosis was evident in the CC of the BCAS
group. Astrocytes are sensitive to various stimuli, e.g.
Fig. 3 GFAP and AQP4 distribution in the corpus callosum (CC). a(A–F) Representative images of double immunofluorescent staining for GFAP
and AQP4 in the corpus callosum (CC). a(A) Sham-std; a(B) Sham-3 h; a(C) Sham-full; a(D) BCAS-std; a(E) BCAS-3 h; a(F) BCAS-full. Scale bar represents
10 μm. a(A-C) In Sham subgroups, AQP4 was normally distributed within the astrocytic end-feet around the vessels (arrow heads). a(D) and a(F) In BCAS
subgroups, AQP4 was abnormally aggregated at the periphery of GFAP-positive astrocytes/clasmatodendrocytes, especially in BCAS-std and BCAS-full
subgroups (arrows). a(E) In limited exposure to EE (BCAS-3 h), less abnormal distribution of AQP4 was seen in the CC. b Histogram showing % AQP4
dislocation in each group. EE, especially by limited exposure to EE (BCAS-3 h) attenuated AQP4 dislocation in the CC (**P < 0.01). Sham-std, n = 11;
Sham-3 h, n = 11; Sham-full, n = 11; BCAS-std, n = 13, BCAS-3 h, n = 10; BCAS-full, n = 12
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Fig. 4 Assessment of microglial proliferation and activation in the corpus callosum (CC). a (A–F) Representative images of Iba-1 stained corpus
callosum (CC) in each group. a(A) Sham-std; a(B) Sham-3 h; a(C) Sham-full; a(D) BCAS-std; a(E) BCAS-3 h; a(F) BCAS-full. Scale bar represents
50 μm. a(A) Inset showing a normal microglial cell. a(D) Inset showing activated microglial cells. b, c Histograms showing degree of microglial
proliferation in each subgroup. EE, especially by limited exposure to EE (BCAS-3 h) suppressed microglial proliferation in the CC induced by
BCAS (**P < 0.01). d–f Histograms showing degree of microglial activation in each subgroup. Limited exposure to EE suppressed degree of
microglial activation in both moderate (microglial cell body >7 μm) (**P < 0.01) (d) and highly (microglial cell body >10 μm) activated (*P < 0.05)
(e) levels, as well as suppressed the number of non-activated microglial cells (**P < 0.01) (f). However, BCAS-full did not show suppressed highly
activated microglia in the CC (e). Sham-std, n = 11; Sham-3 h, n = 11; Sham-full, n = 11; BCAS-std, n = 13, BCAS-3 h, n = 10; BCAS-full, n = 12
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ischaemia, and transform themselves to reactive cells
upon stimulation. It is known that protoplasmic astro-
cytes lose their integrity faster than fibrous astrocytes
[27, 46]. In the human white matter (WM), most of the
astrocytes represent the fibrous form [47]. In our study,
the astrogliosis appears to accord with the fibrous type
(Fig. 2a), suggesting that fibrous type of astrocytes ac-
quires characteristics of GFAP-positive reactive astro-
cytes or clasmatodendrocytes after BCAS. Furthermore,
we found that the numerical density of clasmatodendro-
cytes in the CC of the BCAS cohort, and percentage of
clasmatodendrocytes per all GFAP-positive astrocytes
were negatively correlated with CC volume. Thus, clas-
matodendrosis was evident in atrophied and damaged
CC induced by cerebral hypoperfusion. This suggests
that clasmatodendrosis is caused via vascular changes,
e.g. pathological alterations in small arteries and blood-
brain-barrier (BBB) disruption [48, 49] following BCAS-
related ischaemic insult, which is compatible with the
findings in human cerebrovascular disease and
Alzheimer’s disease [50]. In reactive astrocytes, p38
mitogen-activated protein kinases (p38 MAPK) is acti-
vated, produce reactive oxygen species (ROS) [51] and
induce cellular inflammation [52], which contributes to
and reinforce an inflammatory cascade. Targeting of as-
trocytes with pharmacological agents that may return
reactive astrocytes to a quiescent phenotype [26] could
represent an important therapeutic treatment for CC
atrophy.
Water homeostasis in brain is regulated by the water
channel family, the aquaporins [53]. In physiological
conditions, aquaporin-4 (AQP4) is present on astrocytic
end-feet around the vessels in the brain [54] and contrib-
utes to water homeostasis and central plasma osmolarity
regulation. AQP4 also play a role in pathophysiologic
conditions, e.g. reduced edema formation after cerebral
ischemia [53, 55]. We previously demonstrated AQP4
immunoreactivity is dislocated in PSD as well as in a
non-human primate model of cerebral hypoperfusion
[44]. We found similar AQP4 disruption in the CC,
a
b
Fig. 5 Nesting ability and cognitive function assessed in the nine-arm radial maze [72, 73]. a(A) Representative images of nest created from the
Nestlet in Sham and BCAS group. a(B) Boxplot showing Nestlet score at baseline level and post operation in each group. a(C, D) Histograms
showing height of the nest (C) and % used Nestlet (D) at baseline level and post operation in each group. BCAS-std subgroup had impaired nesting
ability compared to baseline level (*P < 0.05). EE reversed impaired nesting ability induced by BCAS, especially by limited EE (BCAS-3 h) (a(B)). b(A, B),
Histograms showing number of arm entries before first repeat in all sham and all BCAS (A) as well as number of arm entries before first repeat of each
subgroup (B) assessed in the nine-arm radial maze. Every consecutive 10 sessions and overall 20 sessions were averaged. b(A) All sham completed
more arm entries before first repeat, compared with all BCAS in sessions 1–10, sessions 11–20 and sessions 1–20 (*P < 0.01 vs sham; †P < 0.01 vs sham;
‡P < 0.01 vs sham). b(B) Between BCAS subgroup, BCAS-3 h completed more arm entries compared with BCAS-std and BCAS-full in sessions 1–10,
sessions 11–20 and sessions 1–20. Sham-std, n = 11; Sham-3 h, n = 11; Sham-full, n = 11; BCAS-std, n = 13, BCAS-3 h, n = 10; BCAS-full, n = 12
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compatible with our recent report [56]. Taken together,
AQP4 dislocation and clasmatodendrosis caused by
BCAS may enhance WM pathology (including CC atro-
phy) due to the disturbance of water homeostasis [44].
Notably, limited exposure to EE, rather than full-time
exposure to EE, significantly attenuated clasmatoden-
drosis and AQP4 disruption in the mouse model of
long-term chronic cerebral hypoperfusion. This sug-
gests limited exposure to EE relatively preserves blood-
brain-barrier (BBB) integrity via the maintenance of
glio-vascular integrity after BCAS. Long-term BCAS
can be considered a relevant model as it accurately
mimics glio-vascular pathology seen in VCI/VaD.
BCAS also caused a chronic neuroinflammatory re-
sponse in the WM (CC), indicated by the upregulation
of microglial density in the affected WM region [15, 57].
EE cases of BCAS had considerably reduced microglial
activation/proliferation in comparison to non-enriched
BCAS-std, which is also a novel finding in the BCAS
mouse model. Limited exposure to EE (BCAS-3 h)
showed some effects compared to the sham subgroups,
which indicated that regular limited exposure to EE
showed promise to improve BCAS-induced inflamma-
tion to a similar level shown in sham groups.
Upon activation, microglia undergo fundamental mor-
phological changes in response to different environmen-
tal stimuli. Microglial activation results in hypertrophy,
with thicker and less radially projecting processes [58]
and expresses mitochondrial translocator protein (TSPO)
[59]. The response of microglia might be dependent on
different degrees of activation and may be detrimental
[60]. Tumour necrosis factor-alpha (TNF-α) produced
by activated microglia plays a critical role in the induc-
tion of neuronal death in Alzheimer’s disease [61]. In
addition, increased proliferation of microglia was evident
in human AD cases with increased colony-stimulating
factor 1 receptor (CSF1R) expression, and inhibition of
CSF1R attenuated microglial proliferation in a mice
model of AD [62]. Previous studies have suggested that
chronic over-activation of microglia results in the over-
production of cytotoxic factors such as proteases (i.e.
matrix metalloproteinase-2 (MMP-2)), reactive oxygen
species and pro-inflammatory cytokines [63–65] that
promote neurotoxicity and neuronal damage. Chronic
cerebral hypoperfusion induces MMP-2 in microglia
[66]. MMP-2 plays a critical role in the BBB disruption,
glial activation, and WM lesions after chronic cerebral
hypoperfusion [67]. In our study, BCAS-std and BCAS-
full demonstrated a greater rate of microglial over-
activation, which corresponds to more CC atrophy.
Thus, WM damage observed in BCAS mice may occur
due to microglial activation-induced neuronal/axonal
damage. Identifying molecular targets [68] of microglial
activation and microglial suppressant agents such as
minocycline [69] and ethyl pyruvate [70] could attenuate
microglial activation and protect against brain ischaemia.
With this in mind, we surmise that continuous full-time
environmental enrichment and no enrichment have likely
detrimental effects on WM pathology due to excessive
stimulation of microglial over-activation. It is plausible
that the exacerbated WM injury during continuous full-
time enrichment and no enrichment is partially caused
by the neurotoxic effects of microglial over-activation in-
duced by chronic neuroinflammation [71].
It has been reported that nesting is vital for heat con-
servation, reproduction and shelter and shown to relate
to functional status due to brain lesions, pharmaco-
logical agents and genetic mutations [40]. We found
that BCAS impaired nesting ability, and it was attenu-
ated by EE. BCAS plus limited exposure to EE mice
tended to make better nests compared to other BCAS
subgroups. These results suggest that EE after chronic
cerebral hypoperfusion could protect changes in differ-
ent domains of functional status or attenuate patho-
logical changes, e.g. subtle sensory-motor, pure-motor
deficit and general health conditions involved in nesting
ability. We also utilised an innovative 3D nine-arm ra-
dial arm maze for the assessment of cognitive function,
which is a modified version of the conventional radial
arm maze and designed for assessing working memory
[42]. There were working memory deficits in the ani-
mals with BCAS and improvement in those exposed to
EE, particularly by limited exposure to EE [72, 73]. This
is consistent with the heterogeneity observed in VaD
and normally ageing individuals.
We also suggest the higher mortality in the BCAS-
full subgroup is explained by dehydration and acute
renal failure possibly due to increased overriding phys-
ical activity promoted by the full-time exposure to EE.
Although EE exposes the animals to a number of differ-
ent features including physical exercise and social inter-
action, we noted the average number of wheel rotations
in BCAS-full subgroup was fivefold greater compared
with BCAS-3 h, Sham-3 h and Sham-full subgroups
(data not shown), probably due to disruption of fronto-
subcortical circuit induced by BCAS, which might be a
similar symptom of “disinhibition” seen in patients with
VaD and frontal lobe dysfunction. Furthermore, as lim-
ited exposure to EE group experienced different types
of housing condition (change in housing condition) in
each time when exposed to EE, limited EE could have
initiated and activated the fronto-subcortical circuits
more often when the animals experienced EE housing
every time. In contrast, full-time exposure to EE group
experienced same EE condition for 24 h a day in the
entire 12 weeks of experimental period without changes
in housing condition. Therefore, full-time EE might not
have initiated and activated the fronto-subcortical circuit
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effectively compared with limited EE. Repeated activa-
tion of fronto-subcortical circuits induced by limited EE
could enhance cognitive function and prevent cognitive
decline after BCAS. These observations may explain
why limited exposure to EE was more beneficial than
full-time exposure to EE.
One of the few limitations of our study is that we
assessed glial activation/proliferation only at a single
time point, 16 weeks after surgery. Histological data
obtained from several time points, while cumbersome
would be useful to understand the temporal profile of
glial cell responses as well as effects of EE against astro-
gliosis and microglial activation/proliferation in BCAS.
Another limitation is that we only set limited exposure
to EE regime at 3 h a day. Testing other durations of
limited EE, such as shorter than 3 h will elucidate the
optimal effects of limited exposure to EE against gliosis
and neuroinflammation over a period of time, as little is
known of EE for the most effective way to modify these
pathologies. Finally, greater analysis of all the WM regions
of the cerebrum including the anterior commissure may
have informed on how widespread the described glial re-
sponses occur due to BCAS or cerebral hypoperfusion,
which leads to VCI or VaD.
Conclusions
In summary, long-term chronic cerebral hypoperfusion
induced by BCAS produced similar glial damage, glial
activation and proliferation as evident in VaD. Our study
also demonstrated that limited exposure to EE effectively
suppressed adverse glial activation/proliferation, pre-
served neurovascular/oligovascular units and likely BBB
integrity after chronic cerebral hypoperfusion-induced
vascular insults. By modifying detrimental glial inflam-
matory responses implementing limited EE and even
(poly) pharmacological approaches might be a safe and
effective interventional strategy for cerebrovascular dis-
orders which lead to dementia.
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